Ivabradine Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 5 mg, 7.5 mg, and 9 mg

Reference Brands: Corlanor(US), Procoralan(EU)

Category: Heart Disorder

Ivabradine selectively inhibits funny current (If) channels in the sinoatrial node, lowering heart rate without affecting blood pressure or ventricular contractility. It reduces angina attacks, improves exercise tolerance, and decreases hospitalization risk in chronic heart failure. Benefits include better heart rate control, symptom relief, and improved quality of life. Ivabradine tablet is available in Tablet and strengths such as 5 mg, 7.5 mg, and 9 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ivabradine tablet is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ivabradine tablet can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Ivabradine tablets, marketed as Corlanor (US) and Procoralan (EU), are approved for chronic stable angina and heart failure management. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and quality information, while the EMA ensures compliance with safety and manufacturing standards across European regions. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring regional regulatory adherence supports timely approval, safe use, and worldwide availability of ivabradine tablets, helping improve heart rate management and reduce cardiovascular events globally.